Other Issues

Browse Other Issues Content

Providing coverage for clinically-validated, over-the-counter products capable of preventing complications or replacing higher cost prescriptions through flexible spending arrangements aligns with value-based models working to improve access and outcomes across populations.

Having individual states impose distinct labeling rules would create confusion around critical health details printed on packaging.

Informed Consumer Decision Making

Members of CHPA which market dietary supplements formally initiated a voluntary labeling program on March 22, 2000 which relates to the use of the following label statement on dietary supplement products.

Informed Consumer Decision Making

Members of the Consumer Healthcare Products Association who market dietary supplements containing St. John's wort initiated a voluntary labeling program on April 2, 2000.

The purpose of stability testing is to provide evidence on how the quality of a drug product varies with time under the influence of a variety of environmental factors, such as temperature, humidity, and light, shelf life for the drug product and recommended storage conditions.

The objective of this guideline is to define the minimum stability data package to support the commercial distribution of OTC monograph drug products in the United States per climatic zone.

As a direct result of the PROTECT initiative, CHPA developed a voluntary guideline for industry suggesting ways to standardize volumetric measures in dosing directions and dosing devices for oral pediatric liquid drug products.

Requirements for dietary supplement labels.

While a small select group have raised concerns about certain sunscreen ingredients, banning or restricting common UV filters could negatively impact public health.

Filter Results